UBS Group’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Sell |
121,792
-235,962
| -66% | -$2.25M | ﹤0.01% | 4236 |
|
|
2025
Q1 | $3.74M | Sell |
357,754
-182,358
| -34% | -$1.91M | ﹤0.01% | 3190 |
|
|
2024
Q4 | $12.7M | Sell |
540,112
-85,607
| -14% | -$2.02M | ﹤0.01% | 2135 |
|
|
2024
Q3 | $22.5M | Buy |
625,719
+381,790
| +157% | +$13.7M | ﹤0.01% | 1214 |
|
|
2024
Q2 | $8.61M | Buy |
243,929
+10,602
| +5% | +$374K | ﹤0.01% | 1707 |
|
|
2024
Q1 | $6.62M | Buy |
233,327
+109,277
| +88% | +$3.1M | ﹤0.01% | 1928 |
|
|
2023
Q4 | $1.65M | Buy |
124,050
+69,892
| +129% | +$930K | ﹤0.01% | 3027 |
|
|
2023
Q3 | $485K | Buy |
54,158
+31,589
| +140% | +$283K | ﹤0.01% | 3620 |
|
|
2023
Q2 | $254K | Buy |
22,569
+21,120
| +1,458% | +$238K | ﹤0.01% | 4301 |
|
|
2023
Q1 | $16.7K | Sell |
1,449
-8,127
| -85% | -$93.6K | ﹤0.01% | 6128 |
|
|
2022
Q4 | $111K | Buy |
9,576
+8,530
| +815% | +$98.9K | ﹤0.01% | 4888 |
|
|
2022
Q3 | $13K | Buy |
1,046
+16
| +2% | +$199 | ﹤0.01% | 6917 |
|
|
2022
Q2 | $7K | Sell |
1,030
-9,142
| -90% | -$62.1K | ﹤0.01% | 7430 |
|
|
2022
Q1 | $98K | Buy |
10,172
+9,760
| +2,369% | +$94K | ﹤0.01% | 4929 |
|
|
2021
Q4 | $5K | Buy |
412
+387
| +1,548% | +$4.7K | ﹤0.01% | 8263 |
|
|
2021
Q3 | $0 | Buy |
+25
| New | – | ﹤0.01% | 8437 |
|
|
2021
Q2 | – | Sell |
-3,278
| Closed | -$51K | – | 8323 |
|
|
2021
Q1 | $51K | Sell |
3,278
-6,682
| -67% | -$104K | ﹤0.01% | 5512 |
|
|
2020
Q4 | $209K | Buy |
+9,960
| New | +$209K | ﹤0.01% | 4253 |
|